This study is now enrolling adults with type 1 diabetes who are having difficulty achieving normal blood sugar levels. Its goal is to assess the effect of the investigational use of an oral medication that may help lower Hemoglobin A1c (HbA1c) levels, taken once-a-day as an add-on therapy to insulin, to potentially help diabetics get better control of their blood sugar.
You may be eligible to participate if you meet the following criteria:
If you qualify, you may receive study related:
Medical insurance is not necessary to participate in this study.